MGX
Metagenomi Therapeutics, Inc.Company with tickers: MGX
CIK
1785279
CUSIP
59102M104
Shares Outstanding
37,620,530
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | Wapnick Pamela | Chief Financial Officer | Award | 24,000 |
| 2026-04-01 | Wapnick Pamela | Chief Financial Officer | Award | 144,000 |
| 2026-04-01 | Irish Jian | Director, See Remarks | Award | 46,000 |
| 2026-04-01 | Irish Jian | Director, See Remarks | Other | 292,714 |
| 2026-04-01 | Irish Jian | Director, See Remarks | Award | 276,000 |
| 2026-04-01 | Wein Matthew | See Remarks | Award | 11,000 |
| 2026-04-01 | Wein Matthew | See Remarks | Award | 68,000 |
| 2026-03-05 | Wein Matthew | See Remarks | Sell | 482 |
| 2026-03-05 | Irish Jian | Director, See Remarks | Sell | 1,607 |
| 2026-03-05 | Wapnick Pamela | Chief Financial Officer | Sell | 1,581 |
| 2025-12-05 | Wapnick Pamela | Chief Financial Officer | Sell | 1,576 |
| 2025-12-05 | Irish Jian | Director, See Remarks | Sell | 1,602 |
| 2025-12-05 | Irish Jian | Director, See Remarks | Gift | 228,462 |
| 2025-12-05 | Irish Jian | Director, See Remarks | Other | 292,714 |
| 2025-12-05 | Thomas Brian C. | Director | Sell | 3,830 |
| 2025-12-05 | Wein Matthew | See Remarks | Sell | 199 |
| 2025-12-01 | Irish Jian | Director, See Remarks | Award | 37,500 |
| 2025-12-01 | Irish Jian | Director, See Remarks | Award | 225,000 |
| 2025-12-01 | Wein Matthew | See Remarks | Award | 96,000 |
| 2025-12-01 | Wapnick Pamela | Chief Financial Officer | Award | 120,000 |
| 2025-09-05 | Thomas Brian C. | Director | Sell | 2,701 |
| 2025-09-05 | Irish Jian | Director, See Remarks | Sell | 1,602 |
| 2025-09-05 | Wein Matthew | See Remarks | Sell | 199 |
| 2025-09-05 | Wapnick Pamela | Chief Financial Officer | Sell | 1,576 |
| 2025-09-02 | Reid Laurence | Director | Award | 42,000 |
| 2025-08-11 | Reid Laurence | Director | Other | 0 |
| 2025-06-10 | Dere Willard H | Director | Award | 21,000 |
| 2025-06-10 | BJERKHOLT ERIC | Director | Award | 8,572 |
| 2025-06-10 | Eckhardt Juergen | Director | Award | 21,000 |
| 2025-06-06 | Noonberg Sarah B. | Director | Sell | 5,239 |
| 2025-06-06 | Wapnick Pamela | Chief Financial Officer | Sell | 1,576 |
| 2025-06-06 | Thomas Brian C. | Director | Sell | 10,785 |
| 2025-06-06 | Irish Jian | Director, See Remarks | Sell | 6,390 |
| 2025-06-06 | Wein Matthew | See Remarks | Sell | 199 |
| 2025-04-01 | Irish Jian | Director, See Remarks | Award | 140,000 |
| 2025-04-01 | Irish Jian | Director, See Remarks | Other | 178,483 |
| 2025-04-01 | Irish Jian | Director, See Remarks | Award | 23,000 |
| 2025-04-01 | Wapnick Pamela | Chief Financial Officer | Award | 14,000 |
| 2025-04-01 | Wapnick Pamela | Chief Financial Officer | Award | 84,000 |
| 2025-04-01 | Thomas Brian C. | Director | Award | 32,000 |
| 2025-04-01 | Thomas Brian C. | Director | Award | 196,000 |
| 2025-04-01 | Noonberg Sarah B. | Director | Award | 84,000 |
| 2025-04-01 | Noonberg Sarah B. | Director | Award | 14,000 |
| 2025-04-01 | Wein Matthew | See Remarks | Award | 21,875 |
| 2025-04-01 | Wein Matthew | See Remarks | Award | 3,650 |
| 2025-03-05 | Wapnick Pamela | Chief Financial Officer | Sell | 1,808 |
| 2025-03-05 | Wein Matthew | See Remarks | Sell | 930 |
| 2025-02-03 | BJERKHOLT ERIC | Director | Award | 42,000 |
| 2025-01-27 | BJERKHOLT ERIC | Director | Other | 0 |
| 2024-12-05 | Wapnick Pamela | Chief Financial Officer | Sell | 1,559 |
| 2024-09-05 | Wapnick Pamela | Chief Financial Officer | Sell | 6,265 |
| 2024-04-01 | Noonberg Sarah B. | Director | Award | 57,763 |
| 2024-04-01 | Noonberg Sarah B. | Director | Award | 242,875 |
| 2024-04-01 | Irish Jian | Director, See Remarks | Other | 178,483 |
| 2024-04-01 | Irish Jian | Director, See Remarks | Award | 296,308 |
| 2024-04-01 | Irish Jian | Director, See Remarks | Award | 70,471 |
| 2024-04-01 | Eckhardt Juergen | Director | Award | 78,636 |
| 2024-04-01 | Borges Luis | Chief Scientific Officer | Award | 291,450 |
| 2024-04-01 | Borges Luis | Chief Scientific Officer | Award | 69,316 |
| 2024-04-01 | Wein Matthew | See Remarks | Award | 10,397 |
| 2024-04-01 | Wein Matthew | See Remarks | Award | 43,717 |
| 2024-04-01 | Wapnick Pamela | Chief Financial Officer | Award | 291,450 |
| 2024-04-01 | Wapnick Pamela | Chief Financial Officer | Award | 69,316 |
| 2024-04-01 | Bernales Sebastian | Director | Award | 78,636 |
| 2024-04-01 | Harnest Simon | See Remarks | Award | 48,575 |
| 2024-04-01 | Harnest Simon | See Remarks | Award | 11,552 |
| 2024-04-01 | Delaney Simren | See Remarks | Award | 29,145 |
| 2024-04-01 | Delaney Simren | See Remarks | Award | 6,931 |
| 2024-04-01 | Dere Willard H | Director | Award | 78,636 |
| 2024-04-01 | Thomas Brian C. | Director | Award | 500,323 |
| 2024-04-01 | Thomas Brian C. | Director | Award | 118,992 |
| 2024-02-13 | BAYER HEALTHCARE LLC | 10% Owner | Other | 890,671 |
| 2024-02-13 | BAYER HEALTHCARE LLC | 10% Owner | Other | 1,030,086 |
| 2024-02-13 | BAYER HEALTHCARE LLC | 10% Owner | Other | 1,770,888 |
| 2024-02-13 | BAYER HEALTHCARE LLC | 10% Owner | Other | 2,062,387 |
| 2024-02-13 | BAYER HEALTHCARE LLC | 10% Owner | Other | 3,093,580 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 106,627 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 423,469 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 119,699 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 353,005 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 1,143,905 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 1,896,445 |
| 2024-02-13 | Bernales Sebastian | Director | Other | 513,004 |
| 2024-02-13 | Novo Holdings A/S | 10% Owner | Other | 691,760 |
| 2024-02-13 | Novo Holdings A/S | 10% Owner | Buy | 800,000 |
| 2024-02-13 | Novo Holdings A/S | 10% Owner | Other | 839,175 |
| 2024-02-13 | Novo Holdings A/S | 10% Owner | Other | 147,415 |
| 2024-02-09 | Novo Holdings A/S | 10% Owner | Buy | 100,000 |
| 2024-02-08 | Wapnick Pamela | Chief Financial Officer | Other | 0 |
| 2024-02-08 | Borges Luis | Chief Scientific Officer | Other | 0 |
| 2024-02-08 | Wein Matthew | See Remarks | Other | 0 |
| 2024-02-08 | Dere Willard H | Director | Other | 51,275 |
| 2024-02-08 | Harnest Simon | See Remarks | Other | 111,112 |
| 2024-02-08 | Eckhardt Juergen | Director | Other | 0 |
| 2024-02-08 | BAYER HEALTHCARE LLC | 10% Owner | Other | 0 |
| 2024-02-08 | BAYER HEALTHCARE LLC | 10% Owner | Other | 0 |
| 2024-02-08 | BAYER HEALTHCARE LLC | 10% Owner | Other | 0 |
| 2024-02-08 | BAYER HEALTHCARE LLC | 10% Owner | Other | 0 |
| 2024-02-08 | Bernales Sebastian | Director | Other | 0 |
| 2024-02-08 | Bernales Sebastian | Director | Other | 256,841 |